10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
MERCK & CO., INC. | ||
Ticker: MRK Fiscal Year: 2021 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 25, 2022) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2021 | Dec 31, 2020 | |
Assets | ||
Current Assets | ||
Cash and cash equivalents | $ 8,096 | 8,050 |
Accounts receivable (net of allowance for doubtful accounts of $62 in 2021 and $67 in 2020) | 9,230 | 6,803 |
Inventories (excludes inventories of $2,194 in 2021 and $2,070 in 2020 classified in Other assets - see Note 8) | 5,953 | 5,554 |
Other current assets | 6,987 | 4,674 |
Current assets of discontinued operations | 0 | 2,683 |
Total current assets | 30,266 | 27,764 |
Investments | 370 | 785 |
Property, Plant and Equipment (at cost) | ||
Land | 326 | 336 |
Buildings | 12,529 | 11,998 |
Machinery, equipment and office furnishings | 16,303 | 15,860 |
Construction in progress | 8,313 | 6,968 |
Property, plant and equipment (at cost) | 37,471 | 35,162 |
Less: accumulated depreciation | 18,192 | 18,162 |
Property, plant and equipment, net | 19,279 | 17,000 |
Goodwill | 21,264 | 18,882 |
Other Intangibles, Net | 22,933 | 14,101 |
Other Assets | 11,582 | 9,881 |
Noncurrent Assets of Discontinued Operations | 0 | 3,175 |
Total Assets | 105,694 | 91,588 |
Liabilities and Equity | ||
Current Liabilities | ||
Loans payable and current portion of long-term debt | 2,412 | 6,431 |
Trade accounts payable | 4,609 | 4,327 |
Accrued and other current liabilities | 13,859 | 12,212 |
Income taxes payable | 1,224 | 1,597 |
Dividends payable | 1,768 | 1,674 |
Current liabilities of discontinued operations | 0 | 1,086 |
Total current liabilities | 23,872 | 27,327 |
Long-Term Debt | 30,690 | 25,360 |
Deferred Income Taxes | 3,441 | 1,005 |
Other Noncurrent Liabilities | 9,434 | 12,306 |
Noncurrent Liabilities of Discontinued Operations | 0 | 186 |
Merck & Co., Inc. Stockholders Equity | ||
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2021 and 2020 | 1,788 | 1,788 |
Other paid-in capital | 44,238 | 39,588 |
Retained earnings | 53,696 | 47,362 |
Accumulated other comprehensive loss | (4,429) | (6,634) |
Stockholders' equity before deduction for treasury stock | 95,293 | 82,104 |
Less treasury stock, at cost: 1,049,499,023 shares in 2021 and 1,046,877,695 shares in 2020 | 57,109 | 56,787 |
Total Merck & Co., Inc. stockholders equity | 38,184 | 25,317 |
Noncontrolling Interests | 73 | 87 |
Total equity | 38,257 | 25,404 |
Total Liabilities and Equity | 105,694 | 91,588 |
External Links | |
MERCK & CO., INC. (MRK) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |